Jaźwa, A., Rojo Sanchís, A. I., Innamorato, N. G., Hesse, M., Fernández-Ruíz, J. J., & Cuadrado Pastor, A. (2011). Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism.
Citación estilo ChicagoJaźwa, Agnieszka, Ana Isabel Rojo Sanchís, Nadia G. Innamorato, Marlen Hesse, Javier Javier Fernández-Ruíz, y Antonio Cuadrado Pastor. Pharmacological Targeting of the Transcription Factor Nrf2 At the Basal Ganglia Provides Disease Modifying Therapy for Experimental Parkinsonism. 2011.
Cita MLAJaźwa, Agnieszka, et al. Pharmacological Targeting of the Transcription Factor Nrf2 At the Basal Ganglia Provides Disease Modifying Therapy for Experimental Parkinsonism. 2011.